Carlos Quentin AP

Carlos Quentin undergoes second knee surgery in the past seven months

1 Comment

Bill Center of the San Diego Union-Tribune reports that Carlos Quentin underwent arthroscopic surgery on his right knee yesterday.

This is the same knee that Quentin had surgery on back in March and caused him to miss the first 49 games of the season. He ended up hitting .261/.374/.504 with 16 home runs, 46 RBI and an .877 OPS in 340 plate appearances, but didn’t start 22 out of the final 26 games of the season due to continued pain in the knee.

The good news is that Quentin will be able to participate in offseason workouts and should be ready for the start of spring training, but his injury history is reason for concern. He signed a three-year, $27 million extension with the Padres in July which will pay him $9.5 million in each of the next two seasons and $8 million in 2015. He’ll get at least a $3 million buyout on a $10 million mutual option for 2016 if he plays 320 games over the next three years. Quentin turned 30 years old in August and has never played more than 131 games in a season, so the Padres may not have to worry about that.

Angels sign Kole Calhoun to three-year, $26 million extension

ANAHEIM, CA - SEPTEMBER 26:  Kole Calhoun #56 of the Los Angeles Angels of Anaheim runs to first base during a game against the Oakland Athletics at Angel Stadium of Anaheim on September 26, 2016 in Anaheim, California.  (Photo by Sean M. Haffey/Getty Images)
Sean M. Haffey/Getty Images
Leave a comment

Angels outfielder Kole Calhoun had three more years of arbitration eligibility left, but he and the Angels decided to settle that future business at once on Wednesday, agreeing to a three-year extension worth $26 million, per SB Nation’s Chris Cotillo. The contract also includes a $14 million club option for the 2020 season.

Calhoun, 29, has been a dependable right fielder for the Angels over the last three seasons, batting an aggregate .266/.327/.436 with 61 home runs and 216 RBI in 1,895 plate appearances. According to FanGraphs, Calhoun has been the ninth-most valuable right fielder in baseball since the start of the 2014 season with 11.4 Wins Above Replacement. He ranks slightly behind Giancarlo Stanton (11.9) and just ahead of J.D. Martinez (10.9).

The Angels only have a handful of players signed beyond the 2017 season — just Albert Pujols, Mike Trout, Andrelton Simmons, and Calhoun. The club has options on Ricky Nolasco and Huston Street, while many others will be eligible for arbitration.

Bryce Harper lobbies for Matt Wieters and Greg Holland

WASHINGTON, DC - OCTOBER 13: Bryce Harper #34 of the Washington Nationals reacts after hitting a single in the seventh inning against the Los Angeles Dodgers during game five of the National League Division Series at Nationals Park on October 13, 2016 in Washington, DC. (Photo by Patrick Smith/Getty Images)
Getty Images
Leave a comment

Nothing is happening as the baseball world waits four more hours for the Hall of Fame announcement. Question: why do it at 6pm? For MLB Network ratings? Let’s be real, there are “Golden Girls” reruns on third-tier basic cable that are gonna draw a bigger audience. Why not announce it now so people can get on with their lives? Oh well.

As we wait, let’s take a look in at Twitter, where Jim Bowden of ESPN passes along the rumor that the Washington Nationals are still interested in signing Matt Wieters and Greg Holland:

Great to know that the Nats’ baseball operations budget is dictated by its capital expenditures. Maybe they shoulda been smart like the Braves and suckered — er, I mean negotiated the local government to pay more for it? GO BRAVES!

Anyway, Bryce Harper had a response to that:

I take that to mean that he’d take the money used to construct the team store and give to Wieters and Holland. I haven’t seen the budget breakdown for the new spring training facility, but that would probably mean a major pay cut for Wieters and Holland. And where would we buy our “Make Baseball Great Again” caps? Think ahead, Bryce. Play the long game here.